Dr. Reddy’s Laboratories has launched Montelukast Sodium tablets in 10 mg and Montelukast Sodium Chewable tablets (4 mg & 5 mg).

The drug is a bioequivalent generic version of SINGULAIR® tablets and Chewable tablets.

The Hyderabad-based pharma major launched it in the US market on August 6, following approval by the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA).

The Singular tablets and Chewable tablets brand had US sales of approximately $3.6 billion and $1.14 billion, respectively for the most recent 12 months ended March 31, 2012, according to IMS Health.

Dr. Reddy’s Montelukast Sodium tablets in 10 mg and Montelukast Sodium Chewable tablets in 4 mg and 5 mg are available in bottle counts of 30 and 90, a company release said.

Somasekhar.m@thehindu.co.in

(This article was published on August 7, 2012)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.